Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial.
Elena S GeorgeAnjana ReddyAmanda J NicollMarno C RyanCatherine ItsiopoulosGavin AbbottNathan A JohnsonSiddharth SoodStuart Keith RobertsAudrey C TierneyPublished in: Liver international : official journal of the International Association for the Study of the Liver (2022)
There were no between-group differences for hepatic and metabolic outcomes when comparing MedDiet to LFD. LFD improved IHL and insulin resistance. Significant improvements in visceral fat were seen within both groups. This study highlights provision of dietary interventions in free-living adults with NAFLD is challenging.